Tyra Biosciences, Inc. Share Price
TYRATyra Biosciences, Inc. Stock Performance
Open $31.66 | Prev. Close $31.89 | Circuit Range N/A |
Day Range $30.57 - $31.77 | Year Range $9.99 - $40.42 | Volume 25,649 |
Average Traded $31.29 |
Tyra Biosciences, Inc. Share Price Chart
About Tyra Biosciences, Inc.
Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is TYRA-300, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, thanatophoric dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for bile duct and solid tumors; and TYRA-430 for the treatment of hepatocellular carcinoma. The company was incorporated in 2018 and is headquartered in Carlsbad, California.
Tyra Biosciences, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
22-Jul-26 | $31.66 | $30.65 | +0.00% |
22-Jul-26 | $31.66 | $30.65 | -3.74% |
21-Jul-26 | $31.50 | $31.84 | +2.40% |
20-Jul-26 | $32.09 | $31.09 | -3.16% |
17-Jul-26 | $31.38 | $32.11 | +1.71% |
16-Jul-26 | $31.73 | $31.57 | -2.46% |
15-Jul-26 | $32.76 | $32.37 | -1.60% |